Advocacy Tools
Advocacy materials and tools developed by hepCoalition and partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Includes training materials, community monitoring/data collection, and graphics.
Materials in this section
Global Hepatitis Report 2026
WHO warns current rates of progress are insufficient to meet all 2030 viral hepatitis elimination targets, underscoring the urgent need to accelerate prevention, testing, and treatment efforts worldwide. More
WHO Consolidated Guidance on Hepatitis B and C Prevention, Testing, Treatment, Service Delivery and Monitoring
WHO launches first-ever implementation handbook to accelerate country action on hepatitis elimination. More
WHO Operational Guide: Needle and Syringe Programmes for People Who Inject Drugs
The document provides practical, evidence-based guidance to support countries in planning, implementing and scaling up needle and syringe programmes for people who inject drugs as part of comprehensive harm reduction responses. More
WHO’s New Guidance on Maintaining Opioid Agonist Maintenance Treatment as an Essential Health Service
WHO calls on countries, service planners, providers, policy-makers, and all stakeholders involved in treatment and overdose prevention programmes to ensure live-saving interventions are maintained. More
Global State of Harm Reduction: 2025 Update to Key Data
The 2025 update summarises key developments in harm reduction services, funding and drug policy since the launch of the 9th edition of the report in November 2024. More
WHO Launches New Framework to Tackle Drug Resistance to HIV, Hepatitis B and C, and STIs
The Framework outlines a unified global approach to address drug resistance, a growing threat that risks undermining decades of progress toward ending AIDS and the epidemics of hepatitis B, hepatitis C, and STIs. More
The BOOST Project: A Series of Policy Briefs
The BOOST project supports and strengthens community-based and community-led organisations in Europe in providing communicable diseases services as part of comprehensive, people-centred harm reduction strategies. More
Development Dimensions of Drug Policy: Assessing New Challenges, Uncovering Opportunities, and Addressing Emerging Issues
UNDP releases a discussion paper examining how drug policy affects sustainable development, human rights, governance, health, and the environment. More
European Cities on the Frontline: Harm Reduction and Drug Policy – Needs, Best Practices and Recommendations
C-EHRN releases a report underlining the crucial role of municipal leadership, cross-sectoral cooperation, and community engagement in building resilient harm reduction responses. More
INHSU Report: Six Key Components of Point-of-Care Testing Programs
Findings from the 2025 INHSU Point-of-Care Testing Forum at the Global Hepatitis Summit, held in Los Angeles, USA on 18-21 March 2025. More
